Nicod E - Search Results

1

Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions.

Nicod E, Kanavos P. Nicod E, et al. Health Policy. 2012 Dec;108(2-3):167-77. doi: 10.1016/j.healthpol.2012.09.012. Epub 2012 Oct 22. Health Policy. 2012. PMID: 23088802

2

Developing an evidence-based methodological framework to systematically compare HTA coverage decisions: A mixed methods study.

Nicod E, Kanavos P. Nicod E, et al. Health Policy. 2016 Jan;120(1):35-45. doi: 10.1016/j.healthpol.2015.11.007. Epub 2015 Dec 4. Health Policy. 2016. PMID: 26723201 Review.

3

What is wrong with orphan drug policies? Suggestions for ways forward.

Kanavos P, Nicod E. Kanavos P, et al. Among authors: nicod e. Value Health. 2012 Dec;15(8):1182-4. doi: 10.1016/j.jval.2012.08.2202. Epub 2012 Oct 25. Value Health. 2012. PMID: 23244822 Free article.

4

Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.

Angelis A, Kanavos P, López-Bastida J, Linertová R, Nicod E, Serrano-Aguilar P; BURQOL-RD Research Network. Angelis A, et al. Among authors: nicod e. BMC Health Serv Res. 2015 Sep 28;15:428. doi: 10.1186/s12913-015-1061-3. BMC Health Serv Res. 2015. PMID: 26416027 Free PMC article.

5

Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach.

Nicod E, Jackson TL, Grimaccia F, Angelis A, Costen M, Haynes R, Hughes E, Pringle E, Zambarakji H, Kanavos P. Nicod E, et al. Eur J Health Econ. 2016 Nov;17(8):991-999. doi: 10.1007/s10198-015-0741-6. Epub 2015 Nov 24. Eur J Health Econ. 2016. PMID: 26603298 Free PMC article.

6

SCIENTIFIC AND SOCIAL VALUE JUDGMENTS FOR ORPHAN DRUGS IN HEALTH TECHNOLOGY ASSESSMENT.

Nicod E, Kanavos P. Nicod E, et al. Int J Technol Assess Health Care. 2016 Jan;32(4):218-232. doi: 10.1017/S0266462316000416. Epub 2016 Sep 14. Int J Technol Assess Health Care. 2016. PMID: 27624559

7

Dealing with Uncertainty and Accounting for Social Value Judgments in Assessments of Orphan Drugs: Evidence from Four European Countries.

Nicod E, Berg Brigham K, Durand-Zaleski I, Kanavos P. Nicod E, et al. Value Health. 2017 Jul-Aug;20(7):919-926. doi: 10.1016/j.jval.2017.03.005. Epub 2017 May 3. Value Health. 2017. PMID: 28712621 Free article.

8

Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy.

Jackson TL, Nicod E, Angelis A, Grimaccia F, Prevost AT, Simpson AR, Kanavos P. Jackson TL, et al. Among authors: nicod e. Retina. 2013 Nov-Dec;33(10):2012-7. doi: 10.1097/IAE.0b013e3182a6b3e2. Retina. 2013. PMID: 24013261 Review.

9

PARS PLANA VITRECTOMY FOR DIABETIC MACULAR EDEMA: A Systematic Review, Meta-Analysis, and Synthesis of Safety Literature.

Jackson TL, Nicod E, Angelis A, Grimaccia F, Pringle E, Kanavos P. Jackson TL, et al. Among authors: nicod e. Retina. 2017 May;37(5):886-895. doi: 10.1097/IAE.0000000000001280. Retina. 2017. PMID: 27632713 Review.

10

HTA programme response to the challenges of dealing with orphan medicinal products: Process evaluation in selected European countries.

Nicod E, Annemans L, Bucsics A, Lee A, Upadhyaya S, Facey K. Nicod E, et al. Health Policy. 2019 Feb;123(2):140-151. doi: 10.1016/j.healthpol.2017.03.009. Epub 2017 Mar 28. Health Policy. 2019. PMID: 28400128 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters